Pages that link to "Q33474807"

The following pages link to Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim (Q33474807):

Displaying 35 items.

• EBV finds a polycomb-mediated, epigenetic solution to the problem of oncogenic stress responses triggered by infection (Q38156169) (← links)
• Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation (Q38174306) (← links)
• Epigenetic regulation of the latency-associated region of Marek's disease virus in tumor-derived T-cell lines and primary lymphoma. (Q38330226) (← links)
• Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. (Q38366750) (← links)
• Identification and functional analysis of the BIM interactome; new clues on its possible involvement in Epstein-Barr Virus-associated diseases (Q38453059) (← links)
• The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV in B Cells (Q38597236) (← links)
• Epigenetic Pathways of Oncogenic Viruses: Therapeutic Promises (Q38692795) (← links)
• Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency (Q38724883) (← links)
• RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth. (Q38793717) (← links)
• EBNA3C regulates p53 through induction of Aurora kinase B. (Q38908573) (← links)
• Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines (Q38962956) (← links)
• DNA Methyltransferase Inhibitors: Development and Applications. (Q39003558) (← links)
• Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101. (Q39020172) (← links)
• Dying to protect: cell death and the control of T-cell homeostasis. (Q39277476) (← links)
• Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements (Q39392125) (← links)
• Targeting the regulatory machinery of BIM for cancer therapy (Q39575518) (← links)
• EBV interferes with the sensitivity of Burkitt lymphoma Akata cells to etoposide (Q39633184) (← links)
• Epstein-Barr virus: a master epigenetic manipulator (Q40093402) (← links)
• Uropathogenic Escherichia coli Epigenetically Manipulate Host Cell Death Pathways (Q40888748) (← links)
• Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors. (Q45324502) (← links)
• EBV and Apoptosis: The Viral Master Regulator of Cell Fate? (Q47117102) (← links)
• Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the STK39 Gene in B Cells Infected by EBV. (Q47549184) (← links)
• Differential DNA methylation profiles of human B lymphocytes and Epstein-Barr virus-immortalized B lymphocytes. (Q52653163) (← links)
• Micro RNAs from DNA Viruses are Found Widely in Plasma in a Large Observational Human Population. (Q54229820) (← links)
• The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency. (Q54251658) (← links)
• Counteracting survival functions of EBNA3C in Epstein-Barr virus (EBV)-driven lymphoproliferative diseases by combination of SAHA and bortezomib. (Q55221402) (← links)
• Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis (Q58803477) (← links)
• Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases (Q64100741) (← links)
• Control of viral infections by epigenetic-targeted therapy (Q64110985) (← links)
• Requirement for PRC1 subunit BMI1 in host gene activation by Epstein-Barr virus protein EBNA3C (Q64226563) (← links)
• Epstein-Barr virus (EBV) activates NKL homeobox gene HLX in DLBCL. (Q64999568) (← links)
• HDAC-selective Inhibitor Cay10603 Has Single Anti-tumour Effect in Burkitt's Lymphoma Cells by Impeding the Cell Cycle (Q90259757) (← links)
• T-cell receptor signal strength and epigenetic control of Bim predict memory CD8+ T-cell fate (Q90317657) (← links)
• The interplay between Epstein-Bar virus (EBV) with the p53 and its homologs during EBV associated malignancies (Q91996237) (← links)
• Thymic Function Associated With Cancer Development, Relapse, and Antitumor Immunity - A Mini-Review (Q95272124) (← links)